Institute of Anatomy, Saarland University, Homburg, Germany.
Foot Ankle Int. 2013 Dec;34(12):1742-6. doi: 10.1177/1071100713505535. Epub 2013 Sep 16.
Morbus Ledderhose is a rare hyperproliferative disease of the plantar fascia, leading to the formation of nodules. Its origin is unknown. No causal therapy is available, and treatment remains symptomatic. Various therapeutic strategies to alleviate symptoms are available and are adapted to the severity of the disease. In early stages, conservative therapy including nonpharmacological, physical, and pharmacological treatments is applied. If the disease progresses, irradiation of the plantar surface, injections of steroids, shock wave therapy, and partial or complete fasciectomy as an ultimate therapy may be indicated. Novel experimental treatment options including application of fibrinolytic agents are currently being tested, but no controlled, randomized long-term studies are available. This review aims to provide a systematic overview of current established procedures and outlines novel experimental strategies for the treatment of morbus Ledderhose, including future avenues to treat this rare disease.
莱德尔霍塞氏病是一种罕见的足底筋膜过度增生性疾病,导致结节形成。其病因不明。目前尚无病因治疗方法,治疗仍以对症治疗为主。有多种缓解症状的治疗策略可供选择,并根据疾病的严重程度进行调整。在早期阶段,采用包括非药物、物理和药物治疗在内的保守治疗。如果疾病进展,可能需要对足底表面进行放射治疗、类固醇注射、冲击波治疗以及部分或完全筋膜切开术作为最终治疗。目前正在测试包括纤维蛋白溶解剂应用在内的新型实验治疗选择,但没有对照、随机的长期研究。本综述旨在对现有的既定程序进行系统概述,并概述莱德尔霍塞氏病的新型实验治疗策略,包括治疗这种罕见疾病的未来途径。